O

Ocular Therapeutix

OCUL

8.07000
USD
-0.4
(-4.72%)
Market Open
Volume
8,429
EPS
0
Div Yield
0
P/E
-10
Market Cap
1,740,086,005
Related Instruments
D
DRIO
-0.09000
(-8.18%)
1.01000 USD
M
MCRB
-0.10000
(-7.41%)
1.25000 USD
O
OCUP
-0.13000
(-6.53%)
1.86000 USD
P
PSNL
0.10000
(2.89%)
3.56000 USD
S
SLNO
0.870
(1.80%)
49.320 USD
News

Title: Ocular Therapeutix

Sector: Healthcare
Industry: Biotechnology
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.